CR7795A - TETRALINOS AND INDANES SUBSTITUTES - Google Patents

TETRALINOS AND INDANES SUBSTITUTES

Info

Publication number
CR7795A
CR7795A CR7795A CR7795A CR7795A CR 7795 A CR7795 A CR 7795A CR 7795 A CR7795 A CR 7795A CR 7795 A CR7795 A CR 7795A CR 7795 A CR7795 A CR 7795A
Authority
CR
Costa Rica
Prior art keywords
tetralinos
indanes
substitutes
tetralin
modulators
Prior art date
Application number
CR7795A
Other languages
Spanish (es)
Inventor
Xiaoli Chen
Jay M Matthews
Jung Lee
Philip Rybczynski
Keith T Demarest
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CR7795A publication Critical patent/CR7795A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención tiene como caracteristica compuestos de tetralina e indano, composiciones que los contienen y métodos de uso de los mismos como moduladores del PPAR alfa, para tratar o inhibir la progresión de por ejemplo la diabetes.The invention has as its characteristic tetralin and indane compounds, compositions containing them and methods of use thereof as modulators of PPAR alpha, to treat or inhibit the progression of, for example, diabetes.

CR7795A 2002-10-21 2005-04-18 TETRALINOS AND INDANES SUBSTITUTES CR7795A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41993502P 2002-10-21 2002-10-21
US49527003P 2003-08-15 2003-08-15

Publications (1)

Publication Number Publication Date
CR7795A true CR7795A (en) 2012-10-25

Family

ID=32179771

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7795A CR7795A (en) 2002-10-21 2005-04-18 TETRALINOS AND INDANES SUBSTITUTES

Country Status (17)

Country Link
EP (1) EP1569897A1 (en)
JP (1) JP2006503916A (en)
KR (1) KR20050055773A (en)
AU (1) AU2003277441B2 (en)
BR (1) BR0315596A (en)
CA (1) CA2502661A1 (en)
CR (1) CR7795A (en)
EA (1) EA009553B1 (en)
EG (1) EG24842A (en)
HR (1) HRP20050335A2 (en)
MX (1) MXPA05004191A (en)
NO (1) NO20052199L (en)
NZ (1) NZ539510A (en)
PL (1) PL376325A1 (en)
RS (1) RS20050318A (en)
TW (1) TW200418773A (en)
WO (1) WO2004037778A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200500517A1 (en) * 2002-10-21 2005-10-27 Янссен Фармацевтика Н. В. TREATMENT OF SYNDROME X BY SUBSTITUTE TETRALINES AND INDANDS
PL376326A1 (en) * 2002-10-21 2005-12-27 Janssen Pharmaceutica, N.V. Substituted tetralins and indanes and their use
AR048931A1 (en) 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv PROCESS FOR THE PREPARATION OF SUBSTITUTED AND INDIAN TETRALIN DERIVATIVES AND PREPARATION OF SYNTHESIS INTERMEDIARIES
AU2005302669A1 (en) * 2004-10-27 2006-05-11 Neurogen Corporation Diaryl ureas as CB1 antagonists
NZ568488A (en) 2005-12-22 2011-07-29 High Point Pharmaceuticals Llc Phenoxy acetic acids as PPAR delta activators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606805D0 (en) * 1996-03-30 1996-06-05 Glaxo Wellcome Inc Medicaments
GB9822473D0 (en) * 1998-10-16 1998-12-09 Glaxo Group Ltd Chemical compounds
WO2001060807A1 (en) * 2000-02-18 2001-08-23 Merck & Co. Inc. Aryloxyacetic acids for diabetes and lipid disorders
JP2004510757A (en) * 2000-10-05 2004-04-08 バイエル　アクチェンゲゼルシャフト Propionic acid derivative
AU2002222549A1 (en) * 2000-11-29 2002-06-11 Kyorin Pharmaceutical Co. Ltd. Substituted carboxylic acid derivatives
JPWO2002046146A1 (en) * 2000-12-05 2004-04-08 杏林製薬株式会社 Substituted carboxylic acid derivatives
JP2004517100A (en) * 2000-12-20 2004-06-10 グラクソ　グループ　リミテッド Substituted oxazoles and thiazoles as hPPARalpha agonists
BR0207227A (en) * 2001-02-15 2004-02-10 Pfizer Prod Inc Ppar proliferating activated receptor compounds
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
EA200500517A1 (en) * 2002-10-21 2005-10-27 Янссен Фармацевтика Н. В. TREATMENT OF SYNDROME X BY SUBSTITUTE TETRALINES AND INDANDS
PL376326A1 (en) * 2002-10-21 2005-12-27 Janssen Pharmaceutica, N.V. Substituted tetralins and indanes and their use

Also Published As

Publication number Publication date
JP2006503916A (en) 2006-02-02
WO2004037778A1 (en) 2004-05-06
PL376325A1 (en) 2005-12-27
NZ539510A (en) 2008-01-31
MXPA05004191A (en) 2006-01-27
AU2003277441A1 (en) 2004-05-13
TW200418773A (en) 2004-10-01
AU2003277441B2 (en) 2009-05-07
KR20050055773A (en) 2005-06-13
RS20050318A (en) 2007-09-21
BR0315596A (en) 2005-09-06
EP1569897A1 (en) 2005-09-07
EA009553B1 (en) 2008-02-28
EG24842A (en) 2010-10-13
EA200500515A1 (en) 2005-10-27
CA2502661A1 (en) 2004-05-06
HRP20050335A2 (en) 2006-05-31
NO20052199L (en) 2005-06-24

Similar Documents

Publication Publication Date Title
MX2022007576A (en) Irak degraders and uses thereof.
NI202100018A (en) MODULATORS OF PNPLA3 EXPRESSION
UY30846A1 (en) OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
UY37589A (en) MODULATING COMPOUNDS OF ARYLIC HYDROCARBON RECEIVER (AhR)
UY37590A (en) MODULATING COMPOUNDS OF ARYLIC HYDROCARBON RECEIVER (AhR)
CL2007002384A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment of psoriasis.
ECSP077319A (en) ACIDS 4 - ((PHENOXIALQUIL) UNCLE) -PHENOXYACETICS, AND ANALOGS OF THE SAME
CR9663A (en) 1,4-DIHYDROPIRIDINE-CONDENSED HETEROCICLES, PROCESSES TO PREPARE THE SAME, USE AND COMPOSITIONS CONTAINING THEM
PA8577201A1 (en) 3-PHENYL-PROPIONAMIDE, 3-PHENYL-ACRYLAMID AND DERIVATIVES 3-PHENYL-PROPINAMID AS MAO-B INHIBITORS
PE20210109A1 (en) IRF4 EXPRESSION MODULATORS
CY1110326T1 (en) SUBSTITUTED TETRALINS AND INDIA AND THEIR USE
ECSP077320A (en) ACIDS 4 - ((PHENOXIALQUIL) UNCLE) -PHENOXYACETICS AND ANALOGS
CR7868A (en) COMBINATION FOR THE TREATMENT OF THE DISORDER FOR DEFICIT OF CARE WITH HYPERACTIVITY
AR047553A1 (en) THE COMBINATION OF A SEROTONINE AND AGOMELATINE REABSORTION INHIBITOR
UY28731A1 (en) CHEMICAL COMPOUNDS
CL2009000599A1 (en) Compounds derived from substituted 4,5-dihydro-1h-pyrazol (4,3-g) benzothiazole; pharmaceutical composition; Useful for the treatment and prevention of cancer, infections, inflammatory and autoimmune diseases, among others.
CR7795A (en) TETRALINOS AND INDANES SUBSTITUTES
BR0315566A (en) Substituted tetralines and indans
UY38472A (en) FOXP3 EXPRESSION MODULATORS
AR038898A1 (en) COMPOSITIONS FOR HAIR TREATMENT
MX2020003554A (en) MODULATORS OF ENaC EXPRESSION.
AR117079A1 (en) FOXP3 EXPRESSION MODULATORS
CO2025016192A2 (en) Molecules and methods of using these
ECSP066628A (en) INDOL-O-GLUCOSIDS REPLACED

Legal Events

Date Code Title Description
FC Refusal